Mouse TNFSF11/RANKL ELISA Kit PicoKine® EK0843 from BosterBio

Product Specs
ItemMouse TNFSF11/RANKL ELISA Kit PicoKine®
CompanyBosterBio
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberEK0843
Quantity96 wells/kit, with removable strips
Detection Range15.6 pg/ml - 1,000 pg/ml
ReactivityMouse
Sensitivity<10 pg/ml
NCBI Gene AliasesLy109l, ODF, OPGL, RANKL, Trance
Sample Typecell culture supernatants, cell lysates, serum and plasma (heparin, EDTA)
Gene NameTumor necrosis factor ligand superfamily member 11
ImmunogenExpression system for standard: NS0; Immunogen sequence: R72-D316
ApplicationsELISA
Anticoagulantheparin or EDTA
Molecular Weight35003 MW
Assay Time15-25min
Brand/TrademarkBoster
Research AreaAdaptive Immunity, Atherosclerosis, Cardiovascular, Cytokines, Cytoskeleton / Ecm, Extracellular Matrix, Immunology, Innate Immunity, Signal Transduction, Structures, Tnf Superfamily
NCBI Full Gene Nametumor necrosis factor (ligand) superfamily, member 11
StorageStore at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles (Ships with gel ice, can store for up to 3 days in room temperature. Freeze upon receiving.)
Detection TargetTNFSF11

3942 B Valley Ave.

Pleasanton, CA 94566

United States

Phone: (888) 466-3604
Fax: (925)215-2184

Email: support@bosterbio.com

(1) REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulationFASEB journal : official publication of the Federation of American Societies for Experimental BiologyJune 1, 2018Song C, Tan P, Zhang Z, Wu W, Dong Y, Zhao L, Liu H, Guan H, Li F.

(2) Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and OsteoclastsStem cell reportsJune 6, 2017Wu H, Wu Z, Li P, Cong Q, Chen R, Xu W, Biswas S, Liu H, Xia X, Li S, et al.

(3) Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXRFrontiers in pharmacologyJanuary 1, 2017Guo J, Li W, Wu Y, Jing X, Huang J, Zhang J, Xiang W, Ren R, Lv Z, Xiao J, et al.

(4) Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast ActivityFrontiers in pharmacologyJanuary 1, 2017Zhao L, Cai C, Wang J, Zhao L, Li W, Liu C, Guan H, Zhu Y, Xiao J.

(5) An in vitro 3D bone metastasis model by using a human bone tissue culture and human sex-related cancer cellsOncotargetNovember 22, 2016Salamanna F, Borsari V, Brogini S, Giavaresi G, Parrilli A, Cepollaro S, Cadossi M, Martini L, Mazzotti A, Fini M.

(6) Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone LossScientific reportsSeptember 4, 2015Zhang Y, Guan H, Li J, Fang Z, Chen W, Li F.

(12) Hypoxia induces RANK and RANKL expression by activating HIF-1α in breast cancer cellsBiochemical and biophysical research communicationsMay 13, 2011Tang ZN, Zhang F, Tang P, Qi XW, Jiang J.

Mouse TNFSF11/RANKL ELISA Kit PicoKine